Market revenue in 2021 | USD 68.6 million |
Market revenue in 2030 | USD 569.6 million |
Growth rate | 26.5% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.18% in 2021. Horizon Databook has segmented the South Korea ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is rapidly becoming recognized as a leader in clinical research, technological advancements, and adoption of better solutions for enhanced clinical trials. Development of better solutions by local players and various strategic initiatives undertaken by local & international players for improving clinical outcomes are among factors anticipated to fuel market growth.
The country has one of the most efficient clinical trial approval processes of 30 working days. Presence of research-intensive environment, high expenditure on R&D, and availability of advanced IT infrastructure with highly educated & motivated resources and sites in Korea, which enhance quality & efficiency in clinical trials, are expected to fuel market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into South Korea ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account